Knowledge, Attitude and Practice Regarding Pharmacovigilance and Consumer Pharmacovigilance among Consumers at Lalitpur District, Nepal
Keywords:
Adverse drug reaction, consumers, reporting systemsAbstract
Background: Adverse drug reactions (ADRs) can be a big threat to the health of people in Nepal as a variety of medicines are consumed in the country. Involving consumers in pharmacovigilance can strengthen ADR reporting. The study aims to find out knowledge, attitude and practice regarding pharmacovigilance and consumer pharmacovigilance among consumers at Lalitpur district, Nepal
Methods: It was carried out in outpatients visiting in KIST Medical College and Teaching Hospital, Lalitpur, Nepal. Participant’s knowledge, attitude and practice were measured by noting their agreement with a set of 21 statements along with multiple choice and open ended questions.
Results: A total of 157 outpatients were surveyed. The knowledge scores for males (12) was better compared to the females (11), but the scores for attitude and practice were same for both groups. The maximum score for knowledge was 29, attitude was 6 and practice was 10. The overall KAP scores was 45. The total scores for knowledge, attitude and practice for males (24) were better compared to female (22) respondents. Seventy-one patients (68%) who participated in this study favoured establishing a consumer centre for obtaining information about ADRs.
Conclusions: Knowledge scores among consumers regarding pharmacovigilance is low and require advocacy and improvement.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Submission of the manuscript means that the authors agree to assign exclusive copyright to JNHRC. The aim of JNHRC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact. Hence, JNHRC grants permission to read, download, copy, distribute, print, search, or link to the full texts of these articles which is available online (http://jnhrc.com.np) freely.
The articles in this journal are licensed under a Creative Commons Attribution 4.0 International License.